Denise Wootten and Patrick Sexton on class B GPCR pharmacology and biased agonism at the GLP-1 receptor Following the Question, Not the Credential Zhao describes her decision to pursue a postdoc as emerging understand" 19:38 Why Australia - how a single conference in Melbourne redirected the next chapter 22:28 The decision

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance

Biotech Leaders & Scientists Actionable Data Insights: Translate complex GPCR pharmacology into clear decisions to remove roadblocks, enhance execution, and generate actionable scientific data, driving confident decisions This partnership prevents bottlenecks and optimizes resource allocation, ensuring every strategic decision This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory Yamina brings the clarity, rigor, and structured decision-making that keeps programs on track.

Take your idea, platform, or early data and turn it into a strategic roadmap with clear decisions, timelines How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data Prioritize assays based on project phase and decision points Map go/no-go logic that guides program momentum confidence Trusted by Biotech Innovators Before working with Yamina, we were navigating challenging decisions You walk away with a decision-ready roadmap, improved CRO output, and faster movement through your discovery

Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade Translate project strategy into clear decision-driving assays Eliminate “nice to have” tests that stall I bring structure, decision frameworks, and momentum so your team stays on track. I’ve worked with her on several discovery programs; in fragmented programs, she brought clarity and decision

“The data looks fine, but it doesn’t help us make decisions.” and reduce delays • Align teams across roles—from assay execution to client updates Data Turns Into Decisions—Not science into clear deliverables • Define program objectives and guide assay plans that support partner decisions

system choice does to bias estimates Translating pathway-level data into lead selection and optimization decisions Why potency alone is not enough for candidate-level decisions 📅 May 28, 2026 at 11:00:00 AM Details Walk away with something you can apply in your next experiment, assay, or project decision.

.” — Alex Serafini Decision-Making: Saying Yes to the Unorthodox Path Serafini’s journey defied traditional His approach to decision-making is pragmatic: follow impact, not orthodoxy. The decision to stay on as a postdoc in the same lab as his PhD — with Dr.

for Biotech Growth Operational System Design (OS) Cross-functional Team Alignment Scaling Protocols & Decision In reality, something more subtle starts to shift. 👉 Decision-making changes.

Choosing the readout is a scientific decision, not only a throughput decision. Martin Marro "It was inevitable to ask myself whether I had made the right decision.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

ortholog connections, from fly adhesion GPCRs to vertebrate vascular and neurological disease Career decisions The decision to stay came from a specific opportunity, a specific mentor, and a specific set of questions Introduction of Beatriz Blanco-Redondo; icebreaker 01:15 - Career path: from Spain to Germany, and the decision

Valuable and Accessible Property of New Drug Candidates Turning functional selectivity into a practical decision-making out loud, and where receptor theory, biased signaling, and the pharmacology of real drug discovery decisions

Family First, Always The decision to shift from academia to industry wasn’t driven by disillusionment—it This pragmatic decision led him to high-throughput screening at DuPont, proving that scientific ambition

Science Journey and Postdoc Decision Mike discussed his journey into science and his decision to pursue Career Trajectory and Faculty Position Yamina and Mike discussed Mike's career trajectory and his decision

I want to connect more trainees with diverse career resources to support professional decision-making opportunities of my peers, in combination with my own scientific endeavors, will inform my future career decisions

homology between targets like CXCR1 and CXCR2 makes immunogen selection a critical and underappreciated decision persists, and what systematic characterization requires Immunogen selection as the critical upstream decision Inside a company, you understand the full range of decisions - immunogen design, host selection, production

Decision-Making: From Researcher to Scientific Leader Maria’s story is one of trusting her instincts I wasn’t sure at first, but I realized I could do this too.” — Maria Majellaro Her decisions, often made

scale 10:16 Lessons for the next one, and the shape of the new normal Selected Quotes "So we made a decision Montreal being the epicenter of the disease in this country — we don't regret that decision now."

scientists interpret pharmacology through the same frameworks, experiments become clearer and program decisions

Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

target and delivering a drug, the challenges of target validation, and the realities of industrial decision-making The CGRP story illustrates how structural biology and pharmacology intersect with corporate decisions

This allows Hauser to study GPCR variant effects in the context of real prescribing decisions, not controlled ethics of population-scale research 10:14 - Origin story - hospital internship, Australia, and the decision

and GPCR Data Analysis For most of GPCR pharmacology's history, affinity was the number that drove decisions off-rate aha moment: seven hours on the receptor versus fifteen minutes 52:22 Founding PharmaChanics: the decision

through the human genome and into a decades-long pursuit of receptors whose functions remain to be written He described it as one of the major single decisions of his career - a bet that the community would respond GPR139 - the full pipeline from sequence to structure 17:21 GPCRDB - origin story, the career-defining decision

Addiction, and the Brain Circuits Alcohol Rewires The brain circuits governing reward, motivation, and decision chronic alcohol produces - not just dampen the pleasure of drinking, but restore the flexibility of the decision

pharmacological tools is not just a technical inconvenience — it is the central obstacle that has shaped every decision adenosine receptor talk that pulled Schulte into GPCRs 11:14 From adenosine to frizzled: the postdoc decision